Researchers at UCL have uncovered why individuals who experience anxiety and depression often struggle with persistent low self-belief in their abilities.

For patients undergoing jaw reconstruction after surgery for head and neck cancer, computer-aided design and manufacturing (CAD/CAM) techniques can improve some key clinical outcomes, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Financial toxicity, the financial distress linked to cancer treatment, significantly impacts patient outcomes. To combat this, the Atrium Health Levine Cancer Institute established a Financial Toxicity Tumor Board in 2019. 

The board is the first known institutional-level intervention of its kind, functioning like a traditional disease-focused multidisciplinary tumor board, but with a singular focus on financial distress. It includes participants from all areas of the cancer center including clinical, supportive and administrative domains. 

Cassandra Pierre, MD, MPH, MSc, assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, has received the Bayard Rustin Award for Courage at the 35^th annual Bayard Rustin Community Breakfast.

CLEVELAND, Ohio (April 30, 2025)—The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others. Bladder health and lower urinary tract issues are examples of topics not well studied. A new study focused on the association of menopause status and use of hormones with bladder and urinary tract health. Results of the study are published online today in Menopause, the journal of The Menopause Society.

A recent study led by the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences has focused on this relationship and its effect on colorectal cancer. The study shows that the single-nucleotide polymorphism rs2355016—a tiny DNA change that some people carry—affects how intratumoral microbiota adhere to tumor cells, promoting CRC progression.